Midline vs PIV is one of the most consequential vascular access decisions you make at the bedside, and most nurses get no formal training in how to make it. Pick wrong and the patient gets stuck again in 72 hours, runs out of peripheral sites, or develops phlebitis from a drug that should never have run through a peripheral line.
This guide is the clinical decision framework. It covers what each device is, how to choose between them, what the Infusion Nurses Society actually says, what you can and cannot infuse through a midline, and the bedside signals that tell you it is time to escalate.
Midline vs PIV: a quick definition
A peripheral IV (PIV) is a short catheter (typically 1 to 1.75 inches) inserted into a peripheral vein in the hand, forearm, or antecubital area, with the tip ending in the same peripheral vein. A midline catheter is a longer catheter (typically 8 to 20 cm) inserted into the basilic, cephalic, or brachial vein in the upper arm, with the tip ending at or near the axillary vein, distal to the shoulder. Both are peripheral devices. Neither is central.
The key technical difference is dwell time. According to data summarized in the NCBI Bookshelf review of midline catheters for IV antibiotics, peripheral IVs typically dwell 3 to 4 days, while midline catheters can dwell 14 to 30 days depending on insertion technique, material, and institutional protocol.
The decision framework: when each device is right
The Infusion Nurses Society's 2021 standards give the cleanest decision framework. Midline catheters are recommended when anticipated therapy duration is 5 to 14 days. Peripheral catheters remain the right choice for shorter durations. Central venous catheters are required for longer durations or for medications that exceed peripheral tolerances.
The CDC adds a related rule: when IV therapy is expected to exceed six days, use a midline catheter or PICC instead of a short peripheral catheter. The reasoning is straightforward. Repeated peripheral restarts damage veins, drive up infection risk, and frustrate patients who already have one foot out the door.
Three questions drive the bedside decision:
- How long is therapy expected to run? Under 5 days, PIV. Five to 14 days, midline. Over 14 days, PICC or port.
- What is being infused? Standard fluids, antibiotics, and most non-vesicant medications can run through either. Vesicants, irritants, parenteral nutrition with greater than 10% dextrose, and continuous chemotherapy require central access, not midline.
- What is the peripheral access reality? A patient with no usable peripheral veins after two failed attempts is a midline candidate even if expected therapy is shorter, because the next stick is the problem.
Comparison table: midline vs PIV at a glance
| Feature | Peripheral IV (PIV) | Midline Catheter |
|---|---|---|
| Catheter length | 1 to 1.75 inches | 8 to 20 cm (3 to 8 inches) |
| Tip location | Same peripheral vein as insertion | Axillary vein, distal to shoulder |
| Typical dwell time | 72 to 96 hours | 5 to 30 days |
| Indication duration | Under 5 days | 5 to 14 days (can extend to 30) |
| Vesicant capable | Limited (rapid push only with monitoring) | No (per INS guidance) |
| Continuous chemotherapy | No | No |
| Parenteral nutrition (>10% dextrose) | No | No |
| Standard antibiotics | Yes | Yes |
| Insertion technique | Blind palpation, traditional landmarks | Ultrasound-guided, sterile field |
| Who places it | RN, LPN, paramedic per scope | Vascular access team, PICC nurse, trained RN |
| Infection risk | Lower per-catheter, higher cumulative with restarts | Lower than PICC, higher than single PIV |
| Cost | $5 to $20 per insertion supply cost | $80 to $200 per insertion plus team fee |
Bottom line: If therapy will run under 5 days and the patient has reasonable peripheral access, place a PIV. If therapy will run 5 to 14 days, request a midline. If therapy is vesicant, irritant, or longer than 14 days, escalate to PICC or port.
INS guidance: the 5-day rule and what it means
The Infusion Nurses Society 2021 Standards of Practice formalized what experienced infusion nurses had practiced informally for years. The 5-day threshold is not arbitrary. Studies analyzed in the PMC review of midline vs PICC outcomes show that PIV failure rates climb sharply after 72 to 96 hours, while midline catheter dwell times stay reliable through day 14 and often beyond.
The practical implication for nurses: when the admission diagnosis suggests therapy beyond 5 days (cellulitis on IV antibiotics, osteomyelitis, complex pneumonia, post-operative infection), advocate for a midline early. Waiting until day 4 to request one means three additional sticks the patient did not need, three more chances to blow a vein, and three more interruptions to therapy continuity.
For broader context on when peripheral lines fail, see our guide on blown veins, causes, and prevention.
What you can run through a midline (and what you cannot)
Midlines accommodate most therapies that PIVs handle, plus tolerate longer dwell times. According to the University of Illinois Chicago Drug Information Group analysis on midline medication considerations, the limiting factors are pH, osmolarity, and vesicant classification.
Appropriate for midline:
- Standard IV fluids (normal saline, lactated Ringer's, dextrose 5%)
- Most IV antibiotics (vancomycin, ceftriaxone, piperacillin-tazobactam at standard concentrations)
- Most analgesics (morphine, hydromorphone, fentanyl)
- Standard electrolyte replacement
- Maintenance fluids and most non-vesicant continuous infusions
Not appropriate for midline:
- Vesicant chemotherapy (vincristine, doxorubicin, anthracyclines)
- Continuous infusions of irritants
- Parenteral nutrition with greater than 10% dextrose final concentration
- Vasoactive infusions (norepinephrine, vasopressin) for sustained periods
- Medications with pH below 5 or above 9 for continuous infusion
- Medications with osmolarity above 900 mOsm/L for continuous infusion
For oncology-specific device decisions, see our guide on IV access in chemotherapy patients, which covers vesicant safety and the PIV-vs-midline-vs-port decision in detail.
What you can run through a PIV (and the real limits)
A PIV in a healthy peripheral vein handles routine therapy well for 72 to 96 hours. The Infusion Nurses Society 2021 Standards retired the old 72-hour mandatory rotation rule and now allows PIVs to dwell as clinically indicated, but functional limits still apply.
PIV is appropriate for:
- Single-dose or short-course IV antibiotics
- Routine maintenance fluids during a 1 to 4 day stay
- Pre-operative access for elective surgery
- Blood draws and lab access in patients with adequate veins
- Emergency department workups with expected disposition under 24 hours
PIV is not appropriate for:
- Continuous vesicant or irritant infusion
- Therapy expected to run beyond 5 days when peripheral access is borderline
- Hypertonic medications or solutions
- Long-term home infusion therapy
The real-world limit is not the catheter, it is the vein. A PIV that needs to be restarted every 48 hours signals a midline conversation, not heroic peripheral access. For matching gauge to therapy, see our IV catheter size selection guide.
Patient-side signals to escalate from PIV to midline
The midline vs PIV call usually announces itself before you formally make it. The clinical judgment skill is recognizing the signals early enough to act on them:
- Two failed PIV attempts on the same encounter. Two misses on a patient with documented difficult access is a midline conversation, not a third stick.
- Visible vein scarring or sclerosis at all preferred sites. Repeated cannulation history shows in the skin. If everything below the antecubital fossa looks roped and bruised, peripheral options are exhausted.
- Therapy duration extending past day 3 with poor PIV tolerance. If you are restarting the line every 24 to 36 hours and the patient still has a week of therapy ahead, escalate.
- Medication change that crosses peripheral tolerance. A patient on standard antibiotics gets switched to a vesicant or hypertonic solution. The PIV is no longer appropriate even if it is patent.
- Patient anxiety or fear of needles compounding access difficulty. Sympathetic vasoconstriction makes every attempt harder. A midline removes the daily access conversation entirely.
- Home infusion or transition to outpatient parenteral antibiotic therapy (OPAT). Discharge planning with planned IV therapy at home is a midline indication, not a PIV expectation.
For the related decision flowchart on when to reach for ultrasound, see our decision guide on when to use ultrasound for IV access.
Scope of practice: who places what
PIV placement is within the scope of practice for registered nurses, licensed practical nurses (with state-specific limits), paramedics, and EMTs in most jurisdictions. Training requirements vary by employer and state board.
Midline placement is more restricted. According to the Health Line Medical Products comparison of PICC and midline catheters, midline insertion is typically performed by:
- Vascular access team nurses (specialized training, usually a hospital-employed team)
- PICC nurses (often the same team that places PICCs and midlines)
- Trained registered nurses with institutional certification
- Physicians and physician assistants in certain settings
The training pathway for midline placement usually requires ultrasound proficiency, sterile technique certification, and a documented number of supervised placements. Many institutions contract with vascular access services rather than training in-house.
This matters for the bedside decision. If your facility does not have a 24-hour vascular access team, midline conversion may take a half-shift to arrange. Plan ahead. Request the consult on day 2 if you anticipate the patient will need it on day 3.
Cost and complication tradeoffs
The economic case for midline over repeated PIVs is well documented. A study in the Gavin Publishers integrative review of PICC and midline complications shows that the upfront cost of midline insertion is offset by avoided PIV restarts, reduced phlebitis treatment, and shorter length of stay associated with reliable access.
A typical comparison for a 10-day antibiotic course:
- PIV approach: 3 to 4 PIV restarts, supplies and nursing time per restart, increased phlebitis risk, occasional therapy interruption
- Midline approach: Single insertion, single supply cost, reliable access through entire course, predictable removal at discharge
Complication profiles differ:
- PIVs have higher cumulative phlebitis risk over multiple insertions, but lower per-catheter infection risk
- Midlines have higher per-catheter infection risk than a single PIV, but lower cumulative risk than 3 to 4 PIV restarts
- Both carry thrombosis risk; midlines slightly higher due to longer catheter and longer dwell time
- Midlines tolerate continuous infusions of standard medications without the breakdown a PIV experiences
For oncology and special populations, the calculus shifts again. See our guide on IV access in chemotherapy patients for vesicant-specific decisions and our guide on IV cannulation in geriatric patients for fragile-vein populations.
How VeinCraft trains for the midline vs PIV decision
Level 2: The Craft covers the clinical decision-making skills behind device selection: PIV vs midline vs PICC vs port, when to escalate, and how to work with vascular access teams. Students practice on patients with difficult access under the observation of credentialed clinical instructors with active field experience. Mastery-based progression means you advance when you demonstrate competence, not when the clock runs out.
If you are new to IV cannulation, start with Level 1: The Method at $199. The 8-hour intensive builds the psychology and technique foundation that makes Level 2 productive. The bundle (Master the Craft) at $449 saves $49 and includes a free practice kit. Enroll in the next cohort when you are ready to stop hesitating on the midline vs PIV call and become the provider others trust to make it.
Frequently asked questions
When should I choose a midline over a PIV?
Choose a midline when anticipated IV therapy will run 5 days or longer, when the patient has limited peripheral access, when the medication regimen requires reliable access for continuous or frequent dosing, or when the patient is transitioning to home infusion. Per Infusion Nurses Society 2021 Standards, the 5-day threshold is the working rule. Below 5 days, a PIV is usually appropriate.
Is a midline considered central access?
No. A midline catheter is a peripheral device. The tip terminates at or near the axillary vein, distal to the shoulder, which is not central. Central venous catheters terminate in the superior vena cava. The midline classification matters because it determines what medications can be safely infused. Vesicants, hypertonic solutions, and continuous chemotherapy require central access, not midline.
Can I run vancomycin through a midline?
Yes, at standard concentrations. Vancomycin at typical hospital infusion concentrations (5 mg/mL or less) is appropriate for midline administration. Higher concentrations or rapid administration may exceed midline tolerance. Verify with your institutional policy and pharmacy. The same general rule applies to most standard IV antibiotics.
How long can a midline catheter stay in?
A midline can dwell 5 to 30 days depending on catheter material, insertion technique, and institutional protocol. Hydrophilic midlines and ultrasound-guided placements consistently achieve longer dwell times. The Infusion Nurses Society 2021 Standards recommend removing midlines based on clinical assessment rather than fixed time limits. Daily site assessment is mandatory.
Who places midline catheters?
Midlines are typically placed by vascular access team nurses, PICC nurses, or registered nurses with institutional certification in midline insertion. Placement requires ultrasound proficiency and sterile technique training. Some facilities use contracted vascular access services rather than maintaining an in-house team. Bedside nurses request a consult, but do not typically place midlines themselves.
What is the difference between a midline and a PICC?
A midline catheter is a peripheral device with the tip ending at or near the axillary vein. A PICC (peripherally inserted central catheter) is a central device with the tip ending in the lower third of the superior vena cava. PICCs handle vesicants, hypertonic infusions, and long-term therapy. Midlines handle non-vesicant therapy lasting 5 to 14 days. The placement technique is similar; the tip location and clinical capability are the difference. The midline vs PIV decision happens further upstream than the midline vs PICC decision, but the same clinical judgment skill underlies both.
VeinCraft Academy is a mastery-focused IV cannulation training program for healthcare professionals. All instruction is delivered by credentialed clinicians with active field experience. VeinCraft Academy is a RevivaGo Company.